The U.S. Department of Labor (DOL) issued an opinion letter stating that the Family and Medical Leave Act (FMLA) may cover time off for employees to participate in clinical trials.
An organization working on finding a cure for a disease requested clarity on FMLA coverage for clinical trial participation, citing concerns about patient participation due to taking time off work.
In response, the DOL clarified that employees can take FMLA leave for the treatment of their own serious health condition, including if it involves participating in a clinical trial.
The coverage extends to treatments involving prescription medication, therapy, or interventions used in clinical trials, regardless of the trial's experimental nature or use of placebos.